Trials / Completed
CompletedNCT04103125
Open, Non-Comparative Study To Evaluate The Performance Of The Medical Device JANESSE®
Open, Non-Comparative Study To Evaluate The Performance And Safety Of The Medical Device JANESSE® (Hyaluronic Acid-Dermal Filler) In The Correction Of Facial Wrinkles
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- I.R.A. Istituto Ricerche Applicate S.p.A. · Network
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of this clinical investigation is that in a population of men and women affected by periocular wrinkles, lip contour wrinkles or deep facial wrinkles, will cross-linked hyaluronic acid (Janesse) significantly decrease the appearance of facial wrinkles, results observed after 4, 8 and 12 weeks.
Detailed description
Janesse®'s action is to increase the volume of dermal-epidermal tissue based on the natural ability of hydrophilic hyaluronic acid molecules to bind to an amount of water many times greater than their weight. This allow to fill the intradermal spaces and integrate the intercellular matrix, conferring turgidity to the tissues. The cross-linking of the hyaluronic acid contained in the product has the effect of more stable and durable filling over time. The Research Question of the present study is the following: in a population of men and women affected by periocular wrinkles, lip contour wrinkles or deep facial wrinkles, will cross-linked hyaluronic acid (Janesse®) significantly decrease the appearance of nasolabial wrinkles, results observed after 12 weeks?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Janesse® is a sterile, injectable, non-pyrogenic, re-absorbable medical product made of reticulated hyaluronic acid of non-animal origin, produced via bacterial fermentation. | The subjects will receive at baseline the first IMD by the Investigator in accordance with the CIP |
Timeline
- Start date
- 2020-07-14
- Primary completion
- 2020-12-21
- Completion
- 2020-12-21
- First posted
- 2019-09-25
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT04103125. Inclusion in this directory is not an endorsement.